CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock Cash Flow
NASDAQ:CNTB - Nasdaq - US2075231017 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.63M | -59.38M | -795.02M | -1.31B | -779.23M | |||
| Depreciation Amortization | 660.00K | 729.00K | 6.94M | 4.08M | 1.45M | |||
| Change In Working Capital | -15.49M | 9.85M | 49.02M | 20.82M | -2.85M | |||
| Taxes Paid | 111.00K | 120.00K | N/A | N/A | N/A | |||
| Other non cash items | 6.85M | 3.79M | 59.39M | 735.30M | 613.47M | |||
| OPERATING CASH FLOW | -23.61M | -47.74M | -679.67M | -544.93M | -167.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -750.00K | -81.00K | -29.32M | -25.25M | -15.30M | |||
| Other Investing Activity | -2.70M | 75.06M | -541.99M | -8.78M | 18.24M | |||
| INVESTING CASH FLOW | -3.45M | 74.98M | -571.31M | -34.03M | 2.93M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -290.00K | -1.52M | -810.00K | -540.00K | |||
| Stock Issued/Repurchased | 194.00K | 1.00K | 890.00K | 1.43B | 923.25M | |||
| Other Financing Activity | 33.00K | 44.00K | 0.00 | -111.44M | -3.95M | |||
| FINANCING CASH FLOW | 227.00K | 45.00K | -630.00K | 1.32B | 918.76M | |||
| Exchange Rate Effect | -595.00K | -568.00K | 94.99M | -40.34M | -53.43M | |||
| CHANGE IN CASH | -27.43M | 26.72M | -1.16B | 696.80M | 701.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -23.61M | -47.74M | -679.67M | -544.93M | -167.16M | |||
| Capital Expenditure | -750.00K | -81.00K | -29.32M | -25.25M | -15.30M | |||
| FREE CASH FLOW | -24.36M | -47.82M | -708.99M | -570.18M | -182.46M | |||
All data in USD